RAC 2.20% $1.78 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-145

  1. 1,379 Posts.
    lightbulb Created with Sketch. 153
    Did you read the part that indicates that RC110 was and is also successful in a current clinical trial?

    You have mentioned it’s doesn’t work
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.